Summary:
- The U.S. Food and Drug Administration (FDA) has approved a new COVID-19 vaccine developed by Moderna.
- The new vaccine is designed to target the latest Omicron variants of the virus and is expected to provide better protection against these variants.
- The approval of this new vaccine is an important step in the ongoing efforts to combat the COVID-19 pandemic and provide people with updated and more effective vaccines.